identified, through multivariate analysis, the risk factors for infection in IIM patients as high-dose glucocorticoid pulse therapy, lymphopenia, ILD, anti- anti-melanoma differentiation-associated protein 5 (MDA5) antibody positivity, and age >50 years (9). This evidence concerns the gene IFIH1 and acquired idiopathic inflammatory myopathy.